State Street Corp Armata Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 40,300 shares of ARMP stock, worth $197,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,300
Previous 40,300
-0.0%
Holding current value
$197,067
Previous $58,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
730KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA260KShares$1.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$511,2290.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$488,9990.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$218,4940.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny38.9KShares$190,2010.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $177M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...